Telomir Pharmaceuticals (NASDAQ: TELO) announced promising preclinical results for Telomir-1, a compound designed to reverse biological aging and e ...
Studies have linked stress with cellular aging as a result of shorter telomeres, which are caps at the ends of chromosomes that help maintain the stability of DNA. With each cell division, telomeres ...
MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking ...
Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. While that might not sound ...